News
Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...
6d
News-Medical.Net on MSNUCLA researchers discover new way to prevent immunotherapy-induced type 1 diabetesA team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor–induced type 1 diabetes, ...
A phase 3 teplizumab trial, of two 12-day courses or placebo given to 328 young people with new-onset type 1 diabetes, was also published in the December 7, 2023, issue of NEJM.That study appeared ...
The immune system starts to recognise insulin-producing cells in the pancreas as something it needs to attack and destroy in people with type 1 diabetes — one of dozens of auto-immune diseases ...
Experimental type 1 diabetes drug shelters pancreas cells from immune system attack. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 04 / 240429133540.htm ...
Because type 1 diabetes is the result of the body’s immune system attacking healthy cells, the disease itself is not directly inherited. However, the risk of being diagnosed with T1DM increases ...
Review Article: Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead.Image Credit: Andrii Yalanskyi / Shutterstock. In a recent study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results